These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 4733)

  • 21. Neurotransmitter receptors in frontal cortex of schizophrenics.
    Bennett JP; Enna SJ; Bylund DB; Gillin JC; Wyatt RJ; Snyder SH
    Arch Gen Psychiatry; 1979 Aug; 36(9):927-34. PubMed ID: 37813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The IGF-I amino-terminal tripeptide glycine-proline-glutamate (GPE) is neuroprotective to striatum in the quinolinic acid lesion animal model of Huntington's disease.
    Alexi T; Hughes PE; van Roon-Mom WM; Faull RL; Williams CE; Clark RG; Gluckman PD
    Exp Neurol; 1999 Sep; 159(1):84-97. PubMed ID: 10486177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GABA receptor binding and endogenous inhibitors in normal human brain and Huntington's disease.
    Olsen RW; Van Ness P; Napias C; Bergman M; Tourtellotte WW
    Adv Biochem Psychopharmacol; 1980; 21():451-60. PubMed ID: 6246754
    [No Abstract]   [Full Text] [Related]  

  • 24. Huntington's chorea: selective depletion of activity of angiotensin coverting enzyme in the corpus striatum.
    Arregui A; Bennett JP; Bird ED; Yamamura HI; Iversen LL; Snyder SH
    Ann Neurol; 1977 Oct; 2(4):294-8. PubMed ID: 214022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea.
    Coyle JT; Schwarcz R
    Nature; 1976 Sep; 263(5574):244-6. PubMed ID: 8731
    [No Abstract]   [Full Text] [Related]  

  • 26. [Biochemical aspects of Huntington's disease].
    Bonilla E
    Acta Cient Venez; 1977; 28(6):391-7. PubMed ID: 24971
    [No Abstract]   [Full Text] [Related]  

  • 27. Postmortem studies of peptides in Alzheimer's disease and Huntington's disease.
    Rossor M; Emson P; Dawbarn D; Dockray G; Mountjoy C; Roth M
    Res Publ Assoc Res Nerv Ment Dis; 1986; 64():259-77. PubMed ID: 2425405
    [No Abstract]   [Full Text] [Related]  

  • 28. Neurotransmitter receptor binding: regional distribution in human brain.
    Enna SJ; Bennett JP; Bylund DB; Creese I; Burt DR; Charness ME; Yamamura HI; Simantov R; Snyder SH
    J Neurochem; 1977 Jan; 28(1):233-6. PubMed ID: 13155
    [No Abstract]   [Full Text] [Related]  

  • 29. Dopaminergic and cholinergic lesions in progressive supranuclear palsy.
    Ruberg M; Javoy-Agid F; Hirsch E; Scatton B; LHeureux R; Hauw JJ; Duyckaerts C; Gray F; Morel-Maroger A; Rascol A
    Ann Neurol; 1985 Nov; 18(5):523-9. PubMed ID: 3000280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An animal model for Huntington's disease.
    Coyle JT
    Biol Psychiatry; 1979 Apr; 14(2):251-76. PubMed ID: 38864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Huntington's chorea. Deficiency of gamma-aminobutyric acid in brain.
    Perry TL; Hansen S; Kloster M
    N Engl J Med; 1973 Feb; 288(7):337-42. PubMed ID: 4345566
    [No Abstract]   [Full Text] [Related]  

  • 32. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers.
    Suzuki M; Desmond TJ; Albin RL; Frey KA
    Synapse; 2001 Sep; 41(4):329-36. PubMed ID: 11494403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rats chronically injected with urine from Huntington's chorea patients do not striatal damage.
    Perry TL; Hansen S; Kish SJ; MacLean J; Berry K
    Life Sci; 1981 Jun; 28(25):2869-74. PubMed ID: 6455580
    [No Abstract]   [Full Text] [Related]  

  • 34. Chemistry of Huntington's chorea.
    Lancet; 1980 May; 1(8178):1119-20. PubMed ID: 6103447
    [No Abstract]   [Full Text] [Related]  

  • 35. Abnormalities of neurotransmitter enzymes in Huntington's chorea.
    Wu JY; Bird ED; Chen MS; Huang WM
    Neurochem Res; 1979 Oct; 4(5):575-86. PubMed ID: 40150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations in L-glutamate binding in Alzheimer's and Huntington's diseases.
    Greenamyre JT; Penney JB; Young AB; D'Amato CJ; Hicks SP; Shoulson I
    Science; 1985 Mar; 227(4693):1496-9. PubMed ID: 2858129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phosphate-activated glutaminase in relation to Huntington's disease and agonal state.
    Butterworth J; Yates CM; Simpson J
    J Neurochem; 1983 Aug; 41(2):440-7. PubMed ID: 6223989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurochemical substrates of rigidity and chorea in Huntington's disease.
    Storey E; Beal MF
    Brain; 1993 Oct; 116 ( Pt 5)():1201-22. PubMed ID: 7693298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regional distribution of neurotransmitter-synthesizing enzymes and substance P within the rat corpus striatum.
    Scally MC; Ulus IH; Wurtman RJ; Pettibone DJ
    Brain Res; 1978 Mar; 143(3):556-60. PubMed ID: 25694
    [No Abstract]   [Full Text] [Related]  

  • 40. Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies.
    Bowen DM; Smith CB; White P; Davison AN
    Brain; 1976 Sep; 99(3):459-96. PubMed ID: 11871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.